MREO · Mereo BioPharma Group plc

Summary

Dr. Annalisa Jenkins informed Mereo BioPharma plc that she will not stand for re-election as a Director at the 2026 annual general meeting scheduled for May 14, 2026. Her decision was not due to any disagreement with the Company or the Board regarding operations, policies, or practices.

Key takeaways

• Dr. Annalisa Jenkins will not stand for re-election as a Director at the 2026 AGM.
• The 2026 annual general meeting is scheduled for May 14, 2026.
• Dr. Jenkins will continue serving until her term expires immediately prior to the 2026 AGM.
• The decision was not due to any disagreement with the Company or the Board.